Anticoagulation Reversal
2 clinical trials · Condition
◉ Watch Anticoagulation Reversal
| Record | Firm | Date |
|---|---|---|
| Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC) (NCT03473132) | Brigham and Women's Hospital | 2018-03-15 |
| Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban (NCT02207257) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-03-01 |
Track Anticoagulation Reversal automatically
Every clearance here is in the API, with alerts when new ones post.